NEW YORK, March 22 (GenomeWeb News) - A new public/private non-profit organization will use the genomic and proteomic research facilities at the Indiana University School of Medicine to conduct heart disease studies, BioCrossroads, which co-founded the entity with IU, said yesterday.
The organization, called the Fairbanks Institute, will coordinate a long-term health study integrating patient data to focus efforts on heart disease prevention and treatment. It will focus on other diseases as well, with the help of a $10 million start-up donation from the Fairbanks Foundation.
The institute will take advantage of Indiana University's genomic and proteomic divisions and of the Indiana Genomics Initiative, according to a statement.
It will also collaborate with the public-private collaboration BioCrossroads and with the Regenstrief Institute.